Report: Canadian biotechs heading for "significant consolidation"

Ernst & Young, which reported on the U.S. biotechnology industry outlook earlier this week, also looked at the Canadian industry and said it expects "significant industry consolidation" to take place this year. The Canadian industry lags behind its U.S. counterparts because it is dominated by small, undercapitalized firms, which nevertheless posted a 21% gain in revenues in 2004 over the previous year.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX